China
· Delayed Price · Currency is CNY Eyebright Medical Technology (Beijing) Statistics
Total Valuation
Eyebright Medical Technology (Beijing) has a market cap or net worth of CNY 14.79 billion. The enterprise value is 15.14 billion.
| Market Cap | 14.79B |
| Enterprise Value | 15.14B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 5, 2024 |
Share Statistics
Eyebright Medical Technology (Beijing) has 189.54 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Shares Outstanding | 189.54M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 21.51% |
| Owned by Institutions (%) | 42.30% |
| Float | 123.18M |
Valuation Ratios
The trailing PE ratio is 42.43 and the forward PE ratio is 29.12.
| PE Ratio | 42.43 |
| Forward PE | 29.12 |
| PS Ratio | 11.99 |
| PB Ratio | 6.56 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.26, with an EV/FCF ratio of -67.21.
| EV / Earnings | 43.40 |
| EV / Sales | 12.31 |
| EV / EBITDA | 31.26 |
| EV / EBIT | 39.87 |
| EV / FCF | -67.21 |
Financial Position
The company has a current ratio of 3.92, with a Debt / Equity ratio of 30.14.
| Current Ratio | 3.92 |
| Quick Ratio | 3.05 |
| Debt / Equity | 30.14 |
| Debt / EBITDA | 1.54 |
| Debt / FCF | -3.32 |
| Interest Coverage | 24.95 |
Financial Efficiency
Return on equity (ROE) is 14.42% and return on invested capital (ROIC) is 8.71%.
| Return on Equity (ROE) | 14.42% |
| Return on Assets (ROA) | 8.21% |
| Return on Capital (ROIC) | 8.71% |
| Revenue Per Employee | 588,259 |
| Profits Per Employee | 166,828 |
| Employee Count | 2,074 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.37% in the last 52 weeks. The beta is 0.38, so Eyebright Medical Technology (Beijing)'s price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -14.37% |
| 50-Day Moving Average | 74.72 |
| 200-Day Moving Average | 82.34 |
| Relative Strength Index (RSI) | 53.78 |
| Average Volume (20 Days) | 1,268,905 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Eyebright Medical Technology (Beijing) had revenue of CNY 1.23 billion and earned 348.84 million in profits. Earnings per share was 1.84.
| Revenue | 1.23B |
| Gross Profit | 864.03M |
| Operating Income | 379.81M |
| Pretax Income | 385.35M |
| Net Income | 348.84M |
| EBITDA | 479.79M |
| EBIT | 379.81M |
| Earnings Per Share (EPS) | 1.84 |
Balance Sheet
The company has 622.82 million in cash and 747.85 million in debt, giving a net cash position of -125.04 million or -0.66 per share.
| Cash & Cash Equivalents | 622.82M |
| Total Debt | 747.85M |
| Net Cash | -125.04M |
| Net Cash Per Share | -0.66 |
| Equity (Book Value) | 2.48B |
| Book Value Per Share | 11.90 |
| Working Capital | 938.72M |
Cash Flow
In the last 12 months, operating cash flow was 254.71 million and capital expenditures -480.00 million, giving a free cash flow of -225.29 million.
| Operating Cash Flow | 254.71M |
| Capital Expenditures | -480.00M |
| Free Cash Flow | -225.29M |
| FCF Per Share | -1.19 |
Margins
Gross margin is 70.24%, with operating and profit margins of 30.88% and 28.36%.
| Gross Margin | 70.24% |
| Operating Margin | 30.88% |
| Pretax Margin | 31.33% |
| Profit Margin | 28.36% |
| EBITDA Margin | 39.01% |
| EBIT Margin | 30.88% |
| FCF Margin | -18.32% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 0.35%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 0.35% |
| Dividend Growth (YoY) | 72.94% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 18.64% |
| Buyback Yield | -0.15% |
| Shareholder Yield | 0.20% |
| Earnings Yield | 2.36% |
| FCF Yield | -1.52% |
Stock Splits
The last stock split was on June 5, 2024. It was a forward split with a ratio of 1.8000180002.
| Last Split Date | Jun 5, 2024 |
| Split Type | Forward |
| Split Ratio | 1.8000180002 |